Publications

Read about our work.

1. A single stent strategy in patients with lifestyle limiting claudication: 3-year results from the Durability II trial.

2015 Jul;86(1):164-70

Catherization & Cardiovascular Intervention: Office journal for the society of Cardio Angiography & interventions

Rocha-Singh KJ, Bosiers M, Schultz G, Jaff MR, Mehta M, Matsumura JS; Durability II Investigators..

2. Twelve-Month Results of the Nitinol Astron Stent in Iliac Artery Lesions.

2016 Nov;27(11):1650-1656

Journal of Vascular & interventional Radiology

Burket MW, Brodmann M, Metzger C, Tan K, Jaff MR.

3. Bioresorbable Everolimus-Eluting Vascular Scaffold for Patients With Peripheral Artery Disease (ESPRIT I): 2-Year Clinical and Imaging Results.

2016 Jun 13;9(11):1178-87

JACC Cardivascular Interventions

Lammer J, Bosiers M, Deloose K, Schmidt A, Zeller T, Wolf F, Lansink W, Sauguet A, Vermassen F, Lauwers G, Scheinert D, Popma JJ, McGreevy R, Rapoza R, Schwartz LB, Jaff MR.

4. Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial.

2016 Apr 12;133(15):1472-83

Circulation

Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB, Machan LS, Snyder SA, O'Leary EE, Ragheb AO, Zeller T; Zilver PTX Investigators..

6. Randomized Trial of Stent versus Surgery for Asymptomatic Carotid Stenosis.

2016 Mar 17;374(11):1011-20

The New England Journal of Medicine

Rosenfield K, Matsumura JS, Chaturvedi S, Riles T, Ansel GM, Metzger DC, Wechsler L, Jaff MR, Gray W; ACT I Investigators..

7. One-year outcomes of the U.S. and Japanese regulatory trial of the Misago stent for treatment of superficial femoral artery disease (OSPREY study).

2016 Feb;63(2):370-6

Journal of Vascular Surgery

Ohki T, Angle JF, Yokoi H, Jaff MR, Popma J, Piegari G, Kanaoka Y; OSPREY investigators..

8. One-Year Outcomes Following Directional Atherectomy of Infrapopliteal Artery Lesions: Subgroup Results of the Prospective, Multicenter DEFINITIVE LE Trial.

2015 Dec;22(6):839-46

Journal of the International society of endovascular Specialist

Rastan A, McKinsey JF, Garcia LA, Rocha-Singh KJ, Jaff MR, Noory E, Zeller T; DEFINITIVE LE Investigators..

9. Durability of Treatment Effect Using a Drug-Coated Balloon for Femoropopliteal Lesions: 24-Month Results of IN.PACT SFA.

2015 Dec 1;66(21):2329-38

Circulation

Laird JR, Schneider PA, Tepe G, Brodmann M, Zeller T, Metzger C, Krishnan P, Scheinert D, Micari A, Cohen DJ, Wang H, Hasenbank MS, Jaff MR; IN.PACT SFA Trial Investigators..

10. Results of the ROADSTER multicenter trial of transcarotid stenting with dynamic flow reversal.

2015 Nov;62(5):1227-34

Journal of Vascular Surgery

Kwolek CJ, Jaff MR, Leal JI, Hopkins LN, Shah RM, Hanover TM, Macdonald S, Cambria RP.

11. A Comparison of Clinical Outcomes for Diabetic and Nondiabetic Patients Following Directional Atherectomy in the DEFINITIVE LE Claudicant Cohort.

2015 Oct;22(5):701-11

Journal of Endovascular Therapy: An official Journal of the International society of endovascular

Garcia LA, Jaff MR, Rocha-Singh KJ, Zeller T, Bosarge C, Kamat S, McKinsey JF.

12. Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease.

2015 Jul 9;373(2):145-53

New England Journal of Medicine

Rosenfield K, Jaff MR, White CJ, Rocha-Singh K, Mena-Hurtado C, Metzger DC, Brodmann M, Pilger E, Zeller T, Krishnan P, Gammon R, Müller-Hülsbeck S, Nehler MR, Benenati JF, Scheinert D; LEVANT 2 Investigators..

13. Wire-Interwoven Nitinol Stent Outcome in the Superficial Femoral and Proximal Popliteal Arteries: Twelve-Month Results of the SUPERB Trial.

2015 May;8(5)

Circulation Cardiovascular Intervention

Garcia L, Jaff MR, Metzger C, Sedillo G, Pershad A, Zidar F, Patlola R, Wilkins RG, Espinoza A, Iskander A, Khammar GS, Khatib Y, Beasley R, Makam S, Kovach R, Kamat S, Leon LR Jr, Eaves WB, Popma JJ, Mauri L, Donohoe D, Base CC, Rosenfield K; SUPERB Trial Investigators..

14. Drug-coated balloons to improve femoropopliteal artery patency: Rationale and design of the LEVANT 2 trial.

2015 Apr;169(4):479-85

American Heart Journal

Jaff MR, Rosenfield K, Scheinert D, Rocha-Singh K, Benenati J, Nehler M, White CJ.

15. Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial.

2015 Feb 3;131(5):495-502

Circulation

Tepe G, Laird J, Schneider P, Brodmann M, Krishnan P, Micari A, Metzger C, Scheinert D, Zeller T, Cohen DJ, Snead DB, Alexander B, Landini M, Jaff MR; IN.PACT SFA Trial Investigators..

16. S.M.A.R.T. self-expanding nitinol stent for the treatment of atherosclerotic lesions in the superficial femoral artery (STROLL): 1-year outcomes.

2015 Jan;26(1):21-8

Journal of Vascular & Interventional Radiology

Gray WA, Feiring A, Cioppi M, Hibbard R, Gray B, Khatib Y, Jessup D, Bachinsky W, Rivera E, Tauth J, Patarca R, Massaro J, Stoll HP, Jaff MR; STROLL Study Investigators..

17. Two-year analysis of the Japanese cohort from the Zilver PTX randomized controlled trial supports the validity of multinational clinical trials.

2014 Oct;21(5):644-53

Journal of Endovascular: An official journal of the international society of Endovascular Specialists

Ohki T, Yokoi H, Kichikawa K, Kimura T, Snyder SA, Ragheb AO, O'Leary EE, Jaff MR, Ansel GM, Dake MD.

18. Human type I pancreatic elastase treatment of arteriovenous fistulas in patients with chronic kidney disease.

2014 Aug;60(2):454-461.e1

Journal of Vascular Surgery

Hye RJ, Peden EK, O'Connor TP, Browne BJ, Dixon BS, Schanzer AS, Jensik SC, Dember LM, Jaff MR, Burke SK

19. Lower extremity revascularization using directional atherectomy: 12-month prospective results of the DEFINITIVE LE study.

2014 Aug;7(8):923-33

JACC: Cardiovascular Interventions

McKinsey JF, Zeller T, Rocha-Singh KJ, Jaff MR, Garcia LA

20. Proper patient selection yields significant and sustained reduction in systolic blood pressure following renal artery stenting in patients with uncontrolled hypertension: long-term results from the HERCULES trial.

2014 Jul;16(7):497-503

The Journal of Clinical Hypertension

Chrysant GS, Bates MC, Sullivan TM, Bachinsky WB, Popma JJ, Peng L, Omran HL, Jaff MR

21. Application of human type I pancreatic elastase (PRT-201) to the venous anastomosis of arteriovenous grafts in patients with chronic kidney disease.

2014 May 3;0(0):0

The Journal of Vascular Access

Dwivedi AJ, Roy-Chaudhury P, Peden EK, Browne BJ, Ladenheim ED, Scavo VA, Gustafson PN, Wong MD, Magill M, Lindow F, Blair AT, Jaff MR, Franano FN, Burke SK

22. Peripheral arterial calcification: prevalence, mechanism, detection, and clinical implications.

2014 May 1;83(6):E212-20

Catheterization and Cardiovascular Interventions

Rocha-Singh KJ, Zeller T, Jaff MR

23. Nitinol stent implantation in the superficial femoral artery and proximal popliteal artery: twelve-month results from the complete SE multicenter trial.

2014 Apr;21(2):202-12

Journal of Endovascular Therapy

Laird JR, Jain A, Zeller T, Feldman R, Scheinert D, Popma JJ, Armstrong EJ, Jaff MR

24. Blood pressure response to renal artery stenting in 901 patients from five prospective multicenter FDA-approved trials.

2014 Mar 1;83(4):603-9

Catheterization and Cardiovascular Interventions

Weinberg I, Keyes MJ, Giri J, Rogers KR, Olin JW, White CJ, Jaff MR

25. Blood pressure response to renal artery stenting in 901 patients from five prospective multicenter FDA-approved trials.

2014 Mar 1;83(4):603-9

Catherization & Cardiovascular Intervention: Office journal for the society of Cardio Angiography & interventions

Weinberg I, Keyes MJ, Giri J, Rogers KR, Olin JW, White CJ, Jaff MR.

26. Stenting and medical therapy for atherosclerotic renal-artery stenosis.

2014 Jan 2;370(1):13-22

New England Journal of Medicine

Cooper CJ1, Murphy TP, Cutlip DE, Jamerson K, Henrich W, Reid DM, Cohen DJ, Matsumoto AH, Steffes M, Jaff MR, Prince MR, Lewis EF, Tuttle KR, Shapiro JI,Rundback JH, Massaro JM, D'Agostino RB Sr, Dworkin LD

28. Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical studies.

2013 Jun 18;61(24):2417-27

Journal of the American College of Cardiology

Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB, Snyder SA, O'Leary EE, Tepe G, Scheinert D, Zeller T

29. Rationale and design of the ATTRACT Study: a multicenter randomized trial to evaluate pharmacomechanical catheter-directed thrombolysis for the prevention of postthrombotic syndrome in patients with proximal deep vein thrombosis.

2013 Apr;165(4):523-530.e3

American Heart Journal

Vedantham S1, Goldhaber SZ, Kahn SR, Julian J, Magnuson E, Jaff MR, Murphy TP, Cohen DJ, Comerota AJ, Gornik HL, Razavi MK, Lewis L, Kearon C

30. Zotarolimus-eluting peripheral stents for the treatment of erectile dysfunction in subjects with suboptimal response to phosphodiesterase-5 inhibitors.

2012 Dec 25;60(25):2618-27

Journal of the American College of Cardiology

Rogers JH, Goldstein I, Kandzari DE, Köhler TS, Stinis CT, Wagner PJ, Popma JJ, Jaff MR, Rocha-Singh KJ

31. Excimer laser with adjunctive balloon angioplasty and heparin coated self expanding stent grafts for the treatment of femoropopliteal artery in-stent restenosis: twelve month results from the SALVAGE trial.

2012; Mar 15

Catheterization and Cardiovascular Interventions

Laird JR, Yeo KK, Rocha-Singh K, Das T, Joye J, Dippel E, Reddy B, Botti C, Jaff MR

32. Nitinol stent implantation vs balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three year follow up of the randomized RESILIENT trial.

2012;19:1-9

Journal of Endovascular Therapy

Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J, Buchbinder M, Dave R, Ansel G, Lansky A, Cristea E, Collins TJ, Goldstein J, Cao AY, Jaff MR.

33. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) Trial.

2012;125:130-9

Circulation: Cardiovascular Interventions

Murphy TP, Cutlip DE, Regensteiner JG, Mohler ER, Cohen DJ, Reynolds MR, Massaro JM, Lewis BA, Cerezo J, Oldenberg NC, Thum CC, Goldberg S, Jaff MR, Steffes MW, Comerota AJ, Ehrman J, Treat-Jacobson D, Walsh ME, Collins T, Badenhop DT, Bronas U, Hirsch AT

34. Significant reduction in systolic blood pressure following renal artery stenting in patients with uncontrolled hypertension: results from the HERCULES trial.

2012

Catheterization and Cardiovascular Interventions

Jaff MR, Bates M, Sullivan T, Popma JJ, Gao X, Zaugg M, Verta P

36. Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: 12-month Zilver PTX randomized study results.

2011;4:495-504

Circulation: Cardiovascular Interventions

Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB, Machan LS, Zeller T, Roubin GS, Burket MW, Khatib Y, Snyder SA, Ragheb AO, White JK

37. Protected carotid stenting in high risk patients: results of the Spider Rx arm of the carotid revascularization with eV3 arterial technology evolution trial.

2010;23:491-8

Journal of Vascular and Interventional Radiology

Safian RD, Jaff MR, Bresnahan JF, Foster M, Bacharach JM, Yadav J, Joye J, Myla S, Kassab E, Mass JT, Ansel GM

38. Two-year clinical evaluation of the Zilver vascular stent for symptomatic iliac peripheral artery disease.

2010;21:1489-94

Journal of Vascular and Interventional Radiology

Jaff MR, Katzen BT

39. Carotid artery revascularization with the NexStent and Filterwire EX/EZ: 3-year results from the CABERNET trial

2010;5:917-24

Eurointervention

Hopkins LN, Myla S, Grube E, Eles G, Dave R, Jaff MR, Allocco D

40. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery. Twelve-month results from the RESILIENT randomized trial.

2010;3:276-76

Circulation: Cardiovascular Interventions

Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J, Buchbinder M, Dave R, Ansel G, Lansky A, Cristea E, Collins TJ, Goldstein J, Jaff MR

41. Safety and effectiveness of the Invatec MoMa proximal cerebral protection device during carotid artery stenting: results of the pivotal ARMOUR trial

2010;76:1-8

Catheterization and Cardiovascular Interventions

Ansel G, Hopkins LN, Jaff MR, Rubino P, Bacharach JM, Scheinert D, Myla S, Das T, Cremonesi A

42. Renal artery stenting with non-invasive duplex follow up: 3-year results from the RENAISSANCE renal stent trial

2008;72:853-62

Catheterization and Cardiovascular Interventions

Rocha-Singh K, Jaff MR, Kelley LE

43. Drug-eluting and bare Nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial.

2006;13:701-710

Journal of Endovascular Therapy

Duda SH, Bosiers M, Lammer J, Scheinert D, Zeller T, Oliva V, Tielbeek A, Anderson J, Wiesinger B, Tepe G, Lansky A, Jaff MR, Mudde C, Tielemans H, Beregi JP

44. Standardized evaluation and reporting of stent fractures in clinical trials of non-coronary devices

2006;13:701-710

Journal of Endovascular Therapy

Jaff MR, Dake MD, Popma JJ, Ansel G, Yoder T

45. Protected carotid stenting in high-risk patients with severe carotid artery stenosis.

2006;47:2384-9

Journal of the American College of Cardiology

Safian RD, Bresnahan JF, Jaff MR, Foster M, Bacharach JM, Maini B, Turco M, Myla S, Eles G, Ansel GM

46. The safety and efficacy of the Starclose Vascular Closure System: the duplex ultrasound substudy of the CLIP study.

2006;68:684-689

Catheterization and Cardiovascular Interventions

Jaff MR, Hadley G, Hermiller JB, Simonton C, Hinohara T, Cannon L, Reisman M, Braden G, Fletcher DR, Zapien M, Chou T, DiDonato K

47. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: Rationale and design of the CORAL trial.

2006;152:59-66

American Heart Journal

Cooper CJ, Murphy TP, Matsumoto A, Steffes M, Cohen DJ, Jaff MR, Kuntz R, Jamerson K, Reid D, Rosenfield KA, Rundback JH, D’Agostino R, Henrich W, Dworkin L

48. Evaluation of the safety and efficacy of renal artery stenting after unsuccessful balloon angioplasty: The ASPIRE-2 Study.

2005 Sep 6;46(5):776-83

Journal of the American College of Cardiology

Rocha-Singh K, Jaff MR, Rosenfield K; ASPIRE-2 Trial Investigators

49. Cryoplasty for the treatment of femoropopliteal arterial disease: results of a prospective multicenter registry.

2005;16:1067-1073

Journal of Vascular and Interventional Radiology

Laird J, Jaff MR, Biamino G, McNamara T, Scheinert D, Zetterlund P, Moen E, Joye JD

50. Protected carotid artery stenting vs endarterectomy in high-risk patients

2004 Oct 7;351(15):1493-501

New England Journal of Medicine

Yadav JS, Wholey MH, Kuntz RE, Fayad P, Katzen BT, Mishkel GJ, Bajwa TK, Whitlow P, Strickman NE, Jaff MR, Popma JJ, Snead DB, Firth BG, Ouriel K.

51. The Nitinol SMART Stent vs. Wallstent for Suboptimal Iliac Artery Angioplasty: The CRISP-US Trial Results.

2004 Sep;15(9):911-8

Journal of Vascular and Interventional Radiology

Ponec D, Jaff MR, Swischuk J, Feiring A, Laird J, Mehran M, Popma JJ, Donohoe D, Firth B, Keim E, Snead D.